ActX is integrated with Greenway PrimeSUITE® Electronic Health Record and is a certified Greenway Marketplace partner.
ActX makes it possible for the first time to bring the power of genomics into your practice, beginning the era of Precision Medicine.
ActX is designed for the busy clinician, who does not have to be an expert in medical genetics.
Integrated into Greenway’s PrimeSUITE EHR, every time your physicians write a prescription, ActX checks the drug against the patient’s genetics, alerting them only if there is an issue with medication efficacy, dosing, or adverse effects. ActX covers almost all U.S prescription drugs for which there is evidence of a genomic effect. For example, a significant percentage of the U.S. population likely gets no pain relief from codeine, based on their genetics, and ActX can alert your clinicians to these patients.
Accessed from within the Greenway electronic chart, the ActX Patient Genomic Profile shows actionable patient genomic risks. For example, patients with Lynch Syndrome, a genetic condition, can have up to a 70% lifetime risk of colorectal cancer, which can be detected at an early stage through colonoscopy starting at a young age.
The ActX Service is evidence based, is continuously updated, includes references, and evaluates the strength of the evidence and the quality of the patient data.
In addition to providing real time genomic decision support, ActX makes it easy to obtain your patient's genetics using a small amount of saliva. It is a full turn-key solution. A physician authorizes a patient for the ActX Service by pressing the ActX Authorization button and confirming the patient's email address. After authorization, your patient will receive an email allowing them to sign up for the ActX service. The patient will then sign up on the actx.com website, pay for the service (the service is currently paid for by patients and not covered by insurance), and receive a saliva collection kit at their home. The patient spits 1 cc of saliva into a tube and then mails it directly to our CLIA certified laboratory, where it will be genotyped or sequenced.
After quality assurance, the ActX Genomic Decision Support service will be activated. The authorizing physician will be alerted by a new message in their inbox when the patient's data is available, and when any immediate or subsequent serious medical risks are found. Every time a prescription is written, it will be checked for drug genomic interactions, and an up to date patient genomic profile can be checked within Greenway PrimeSUITE at any time.
To order the ActX Service, please email Greenway@actx.com
For more details on ActX and Greenway Health: click here
to see our page on the Greenway Health Marketplace page.